Pharmaceutical sciences in 2020.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 99, doi. 10.1038/nrd3087
- By:
- Publication type:
- Article
Works in Nature Reviews Drug Discovery, 2010, Vol 9, Issue 2
Results: 23
1
2
Strategies for treating idiopathic pulmonary fibrosis.
- Published in:
- 2010
- By:
- Publication type:
- journal article
3
Antiplatelet therapies for the treatment of cardiovascular disease.
- Published in:
- 2010
- By:
- Publication type:
- journal article
4
Therapeutic targeting of chemokine interactions in atherosclerosis.
- Published in:
- 2010
- By:
- Publication type:
- journal article
5
Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases.
- Published in:
- 2010
- By:
- Publication type:
- journal article
6
Anti-virulence strategies to combat bacteria-mediated disease.
- Published in:
- 2010
- By:
- Publication type:
- journal article
7
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 85, doi. 10.1038/nrd3098
- Publication type:
- Article
8
Is open innovation the way forward for big pharma?
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 87, doi. 10.1038/nrd3099
- By:
- Publication type:
- Article
9
Ofatumumab.
- Published in:
- 2010
- By:
- Publication type:
- journal article
10
2009 FDA drug approvals.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 89, doi. 10.1038/nrd3101
- By:
- Publication type:
- Article
11
Obesity and diabetes: A new player in type 2 diabetes.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 104, doi. 10.1038/nrd3102
- By:
- Publication type:
- Article
12
Cancer: Anti-CD73 slows tumour growth and spread.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 103, doi. 10.1038/nrd3103
- By:
- Publication type:
- Article
13
Lead discovery: Designing selective PI3K inhibitors.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 105, doi. 10.1038/nrd3104
- By:
- Publication type:
- Article
14
Lead discovery: Enhancing cognition through PDE4 regulation.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 106, doi. 10.1038/nrd3105
- By:
- Publication type:
- Article
15
Tumour immunology: Liver X factor helps tumours escape.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 104, doi. 10.1038/nrd3106
- By:
- Publication type:
- Article
16
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 106, doi. 10.1038/nrd3107
- Publication type:
- Article
17
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 93, doi. 10.1038/nrd3108
- Publication type:
- Article
18
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 96, doi. 10.1038/nrd3109
- By:
- Publication type:
- Article
19
Daniel Vasella.
- Published in:
- 2010
- By:
- Publication type:
- Interview
20
Technology transfer.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 171, doi. 10.1038/nrd3111
- Publication type:
- Article
21
Deal watch: Celgene acquires Gloucester pharmaceuticals, gaining approved HDAC inhibitor.
- Published in:
- 2010
- Publication type:
- journal article
22
Deal watch: dipping into Incyte's JAK-pot.
- Published in:
- 2010
- Publication type:
- journal article
23
Deal watch: M&A activity in 2009.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 2, p. 95, doi. 10.1038/nrd3114
- By:
- Publication type:
- Article